Important: New Login Process
We've updated our access and security system. The first time you log in, enter your work email, and we'll guide you through the process.
- If your organization uses Single Sign-On (SSO), you will be redirected to your company's login portal.
- If you log in with a username and password, you will be prompted to set a new password before accessing your account.
Go to the Login Page to get started.
We appreciate your cooperation during this transition. If you need assistance, please call +1 650-552-4224 or email support@biocentury.com.
- Company Profiles
- Target Profiles
- Product Profiles
Explore BCIQ profiles by entering a company name.
Institut National de la Sante Et de la Recherche Medicale (Inserm)
Biopharma related deals can be found by searching the organization's name in the Deals Module.
BioCentury | Oct 15, 2024
Emerging Company Profile
Commit: Activating the complement pathway to deeply deplete target cells
Launched in May, Danish company’s tech engages C1q to trigger complement-induced killing of cancer or autoimmune cells
BioCentury | Aug 1, 2024
Distillery Therapeutics
Live attenuated E. coli K1 vaccine for neonatal meningitis
BioCentury | Sep 18, 2023
Emerging Company Profile
AbolerIS: testing an antibody to kill effector T cells tied to autoimmunity
University of Nantes spinout heading toward clinic with €27.3M from international syndicate
BioCentury | Oct 4, 2022
Distillery Therapeutics
Gonadotropin releasing hormone for cognition in Down Syndrome
BioCentury | Feb 10, 2022
Discovery & Translation
Translational trendspotting: a Distillery dive into neurology
Highlights include a new approach to the amyloid hypothesis, white space strategies for stroke and gene therapies
BioCentury | Sep 25, 2021
Translation in Brief
Verve’s durable PCSK9 base editor; plus Novartis, PureTech and more
BioCentury’s roundup of translational news
BioCentury | Jul 21, 2021
Finance
French gene therapy play Coave rebrands with €21.2M series B extension
Formerly Horama, Coave is developing targeted therapies for CNS, ocular diseases
BioCentury | Jul 16, 2021
Translation in Brief
Baker lab catches up to DeepMind; plus Casebia, 10X Genomics and more
BioCentury’s roundup of translational news
Items per page:
1 - 10 of 223